Yahoo Finance • 3 months ago
We recently published a list of the 7 Best Performing Long Term Stocks in 2024. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other best performing long term stocks in 2024. Aft... Full story
Yahoo Finance • 3 months ago
We recently compiled a list of the 10 Best Performing Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great-performing stocks. Dow Breaks Record The Dow Jones Indust... Full story
Yahoo Finance • 4 months ago
Insmed Inc's ARIKAYCE remains a key strength with robust market acceptance. Dependence on third-party manufacturers and suppliers presents a notable weakness. Opportunities for growth lie in potential approvals and commercialization of bre... Full story
Yahoo Finance • 7 months ago
BRIDGEWATER, N.J., June 7, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of induceme... Full story
Yahoo Finance • 7 months ago
BRIDGEWATER, N.J., May 28, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it intends to offer... Full story
Yahoo Finance • 7 months ago
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we will dissect whether Insmed Incorporated (NASDAQ:INSM) is a top healthcare pick of elite hedge funds. Challenges in the Health Sector T... Full story
Yahoo Finance • 7 months ago
— ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $75.5 Million for the First Quarter of 2024, Reflecting 16% Annual Growth Over the First Quarter of 2023— —Company Reports Positive Topline Safety and Tolerability Dat... Full story
Yahoo Finance • last year
BRIDGEWATER, N.J., Nov. 29, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will pr... Full story
Yahoo Finance • 2 years ago
In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy Under $20. The biotechnology industry is one of the hottest sectors right now, particul... Full story
Yahoo Finance • 2 years ago
Insmed Incorporated (NASDAQ:INSM) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose 5.0%, resulting in a US$134m rise in the company's market capitalisation. As a result, the stock they origin... Full story
Yahoo Finance • 2 years ago
BRIDGEWATER, N.J., Feb. 9, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its... Full story
Yahoo Finance • 2 years ago
—Topline Data from Phase 2 PK/PD Study of Brensocatib in Patients with Cystic Fibrosis Show Clear Dose Response at all Evaluated Doses— —Treatment Discontinuation Rate of 15% Reported in Postmarketing ARISE Trial of ARIKAYCE® (amikacin li... Full story
Yahoo Finance • 2 years ago
BRIDGEWATER, N.J., Nov. 30, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will pre... Full story
Yahoo Finance • 3 years ago
Just when it looked like time to throw in the towel, the market pulled through and delivered a win. After April turned out to be the worst month since March 2020, May kicked off in a more upbeat fashion, with investors hoping the bottom mi... Full story